Nantahala Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-985,333
Closed -$9.04M 164
2025
Q1
$9.04M Sell
985,333
-698
-0.1% -$4.38K 0.36% 45
2024
Q4
$6.59M Buy
986,031
+28,917
+3% +$255K 0.28% 65
2024
Q3
$9.62M Buy
957,114
+62,531
+7% +$912K 0.49% 40
2024
Q2
$14.4M Buy
894,583
+729,630
+442% +$12.2M 0.84% 22
2024
Q1
$3.61M Sell
164,953
-44,842
-21% -$995K 0.21% 77
2023
Q4
$4.06M Sell
209,795
-10,734
-5% -$196K 0.24% 69
2023
Q3
$4.07M Buy
220,529
+41,751
+23% +$752K 0.35% 64
2023
Q2
$3.3M Buy
178,778
+82,111
+85% +$1.94M 0.32% 66
2023
Q1
$2.8M Hold
96,667
0.21% 67
2022
Q4
$2.68M Buy
+96,667
New +$3.67M 0.17% 70

Nantahala Capital Management's OPTN Position: Q2 2025 in Review

Nantahala Capital Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 985,333 shares — an estimated $9.04M sold.

Nantahala Capital Management first reported a position in OPTN in Q4 2022 and held it in 10 quarters. The position peaked at $14.4M in Q2 2024. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Nantahala Capital Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 985,333 OptiNose shares in Q2 2025, an estimated $9.04M.
  • Nantahala Capital Management first reported a position in OptiNose in Q4 2022 and held it in 10 quarters.
  • Nantahala Capital Management's OptiNose position peaked at $14.4M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Nantahala Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.